This study investigates the mechanical properties as well as in vitro and in vivo cyto- and biocompatibility of collagen membranes cross-linked with glutaraldehyde (GA), proanthocyanidins (PC), hexamethylendiisocyanate (HMDI) and 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EC/NHS). A non-crosslinked membrane was used as reference control (RF). The initial in vitro cytotoxic analyses revealed that the PC, EC, and HMDI crosslinked membranes were cytocompatible, while the GA crosslinked membrane was cytotoxic and thus selected as positive control in the further in vivo study. Cross-linking enhances the tensile strength and collagenase resistance, effectively prolonging the membrane's standing time in vivo. Using (immune-) histochemistry and histomorphometrical analyses, the cellular inflammatory responses, tissue integration and vascularization patterns at 10-, 30-, and 90-day post-implantation in a subcutaneous implantation model in rats were analyzed. The PC membrane elicited the mildest inflammatory cell levels, akin to the RF membrane, while other groups induced an M1-dominated macrophage response and numerous multinucleated giant cells throughout the study period. EC membranes maintained structural stability up to 30Â days post-implantation, similar to the GA group, whereas others collapsed prematurely. Concurrent with membrane collapse, transmembrane vascularization occurred across all groups. Histopathological and histomorphometry results reveal the intricate interplay of inflammatory cell populations in vascularization. These findings offer valuable insights into the pivotal role of cross-linkers in modulating mechanical properties and tissue responses of collagen membranes.
The influence of different crosslinking agents onto the physical properties, integration behavior and immune response of collagen-based barrier membranes.
不同交联剂对胶原蛋白基屏障膜的物理性能、整合行为和免疫反应的影响
阅读:4
作者:Ren Yanru, Alkildani Said, Burckhardt Kim, Köwitsch Alexander, Radenkovic Milena, Stojanovic Sanja, Najman Stevo, Jung Ole, Liu Luo, Barbeck Mike
| 期刊: | Frontiers in Bioengineering and Biotechnology | 影响因子: | 4.800 |
| 时间: | 2024 | 起止号: | 2025 Jan 6; 12:1506433 |
| doi: | 10.3389/fbioe.2024.1506433 | 研究方向: | 免疫/内分泌 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
